Study showed the PETRUSHKA decision-support tool reduced antidepressant discontinuation, supporting personalized treatment approaches.
Andrea Cipriani, MD, PhD
Advertisement
Andrea Cipriani, MD, PhD, from the University of Oxford.
Articles by Andrea Cipriani, MD, PhD
In a randomized trial, PETRUSHKA improved antidepressant continuation and 24-week symptom outcomes by integrating clinical data with patient preferences.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
CT Air Trapping Metric May Predict Post-BLVR Pneumothorax Risk
2
Diabetes Dialogue: The International Diabetes Federation and Care Access in India, With Amit Gupta, MBBS, DNB
3
Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment
4
Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD
5